Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

31,229 signal articles · 0 in last 24h · 160,153 total before filter · latest 1d ago
0last 24h
617last 7d
87● bullish (7d)
65● bearish (7d)
214publishers
AllMacro118Earnings168M&A64Regulatory12Product10Analyst17
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Sigma Lithium marks five years on Nasdaq with second closing bell honor
Proactive15d agoneutral
Sigma Lithium marks five years on Nasdaq with second closing bell honor

Sigma Lithium Corp (TSX-V:SGML, NASDAQ:SGML) will ring the Nasdaq Closing Bell during New York Climate Week, the second time it has received the honor, recognizing its strategy to build the largest lithium oxide industrial mineral producer in the Americas. The ceremony coincides with the...

E-Commerce Update - AI-Powered Student Spaces Revolutionizes Learning With Adobe Acrobat
Simply Wall St.15d agoneutral
E-Commerce Update - AI-Powered Student Spaces Revolutionizes Learning With Adobe Acrobat

Adobe has globally launched Student Spaces in Acrobat for free, providing students a trusted, AI-driven study platform that leverages decades of Adobe's document expertise. Initially released in beta in April 2026, the platform rapidly gained traction with more than 1 million monthly users, offering tools like adaptive flashcards, citation generation, and study guide creation to optimize learning. The latest features aim to enhance learning efficiency, ensure information authenticity, and...

CoreWeave Signs New Compute Contracts at Approximately $40 Million per Megawatt
InvestorsHub15d agoneutral
CoreWeave Signs New Compute Contracts at Approximately $40 Million per Megawatt

CoreWeave (NASDAQ:CRWV) has reported signing new computing capacity contracts at higher prices since 30 June 2026, as the company expands its commitments to customers requiring artificial intelligence infrastructure. During the third quarter of 2026, CoreWeave entered into short-term customer agreements lasting approximately three to six months, with pricing equivalent to around $40 million per megawatt.

Novo Nordisk Publishes Phase 3b Denecimig Results in Haemophilia A
InvestorsHub15d agoneutral
Novo Nordisk Publishes Phase 3b Denecimig Results in Haemophilia A

Novo Nordisk (NYSE:NVO) has published results from its phase 3b FRONTIER5 study of investigational treatment denecimig in the Journal of Thrombosis and Haemostasis, reporting safety, laboratory and patient-experience findings in people with haemophilia A. The study examined whether patients could switch directly from emicizumab to denecimig without requiring a washout period or an initial loading dose.

Why banks blew it on the Clarity Act, while crypto brokers operate as normal
Yahoo Finance Video15d agoneutralVIDEO
Why banks blew it on the Clarity Act, while crypto brokers operate as normal

Scott Melker and Coinbase (COIN) CEO Brian Armstrong discuss how big banks fumbled the Clarity Act by getting caught up in stablecoin rewards, potentially leaving themselves worse off as crypto brokers continue operating as usual. "The Daily Wolf with Scott Melker" airs every day at 12:00 p.m. Tune in for your daily dose of all things crypto.

3 Out-of-Favor Stocks with Warning Signs
StockStory15d agoneutral
3 Out-of-Favor Stocks with Warning Signs

Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investor’s dilemma: bargain opportunity or value trap?

Investing.com15d agoneutral
CoreWeave’s tug-of-war: Record pricing power battles a $3B debt cloud

Investing.com -- CoreWeave (CRWV) shares edged up just 1% on Thursday, caught in a direct clash between red-hot AI compute demand and the heavy gravitational pull of looming dilution. CoreWeave proved exactly how starved the AI market is for capacity. The company revealed it secured short-term Q3 contracts at a staggering $40 million per megawatt in annualized revenue. On top of that premium pricing, CoreWeave racked up over $25 billion in net new customer commitments early in Q3 and expanded it

What's Happening With NBIS Stock?
Trefis15d agoneutral
What's Happening With NBIS Stock?

Nebius Group (NBIS) jumped over 6% in extended trading on September 16 following revised pricing strategies across its on-demand AI compute resources. Yet, the stock remains down roughly 22% over the trailing month due to balance sheet stress, equity dilution fears, and sector rotation. The central tension remains execution: can Nebius convert its massive backlog into revenue before heavy capital commitments squeeze liquidity.

Applied Materials (AMAT) Plans $5 Billion India Semiconductor Research Park
Simply Wall St.15d agoneutral
Applied Materials (AMAT) Plans $5 Billion India Semiconductor Research Park

Applied Materials (NasdaqGS:AMAT) plans to invest US$5b to build a semiconductor research park in India on a 140 acre site. The project is intended to expand the firm’s research and development presence and deepen India’s role in the semiconductor supply chain. Management is positioning the India research park as part of a wider push to integrate the country into Applied Materials’ global operations. This US$5b semiconductor research park in India deserves to be weighed alongside the rest of...

Coherent Corp. (COHR): A Critical Player in AI Data Center Buildouts
Insider Monkey15d agoneutral
Coherent Corp. (COHR): A Critical Player in AI Data Center Buildouts

Baron Capital, an investment management company, released its second-quarter 2026 investor letter for its “Baron SMID Cap ETF”. You can download the letter here. Baron SMID Cap ETF® (BCSM) gained 15.62% (NAV) in the second quarter, underperforming the Russell 2500 Growth Index’s 24.02% return. The trend towards “AI winners” continued, focusing on companies related to chips, […]

What Happens To AbbVie Stock If SKYRIZI Slows Down?
Trefis15d agoneutral
What Happens To AbbVie Stock If SKYRIZI Slows Down?

AbbVie (ABBV) is trading within about one percent of its 52-week high after gaining roughly 24% over the past year, well ahead of the S&P 500. That price rests on two drugs, SKYRIZI above all, growing faster than 20% year over year while the company's older medicines shrink. The biggest risk to the stock makes no noise. It is the chance that this engine slows while the price assumes it cannot.